Home/Filings/4/0000950170-25-076400
4//SEC Filing

Read Simon 4

Accession 0000950170-25-076400

CIK 0001690585other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 4:40 PM ET

Size

5.5 KB

Accession

0000950170-25-076400

Insider Transaction Report

Form 4
Period: 2025-05-22
Read Simon
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-05-22+25,00025,000 total
    Exercise: $18.36Exp: 2035-05-22Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying this stock option award will vest as to one-third of the shares subject to the option on each of the first, second and third anniversaries of the date of grant, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Documents

1 file

Issuer

Dianthus Therapeutics, Inc. /DE/

CIK 0001690585

Entity typeother

Related Parties

1
  • filerCIK 0001688199

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:40 PM ET
Size
5.5 KB